Dyslipidemia treatment guidelines

Aggressive treatment of diabetic dyslipidemia through diet, weight control, and drugs is critical in reducing risk. Diabetics without diagnosed CHD have the same level of risk as nondiabetics with estabhshed CHD. Thus, the dyslipidemia treatment guidelines for diabetic patients are the same as for patients with CHD, irrespective of whether the diabetic patient has had a CHD event. The first line of treatment for diabetic dyslipidemia usually should be a statin. 

Insulin resistance has been associated with a number of other cardiovascular risks, including abdominal obesity, hypertension, dyslipidemia, hypercoagulation, and hyperinsulinemia. The clustering of these risk factors has been termed metabolic syndrome. It is estimated that 50% of the United States population older than 60 years of age have metabolic syndrome. The most widely used criteria to define metabolic syndrome were established by the National Cholesterol Education Program Adult Treatment Panel III Guidelines (summarized in Table 40-2). 

National Cholesterol Education Program (NCEP) Guidelines for Treatment Managing Patients with Dyslipidemia... 

---